data_2e35_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2e35 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.7 mtm . . . . . 0 N--CA 1.49 1.57 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -146.53 119.04 8.47 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.274 -0.891 . . . . 0.0 109.508 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.404 ' HZ2' ' HB2' ' A' ' 3' ' ' LYS . 0.6 OUTLIER -152.24 116.61 5.0 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.293 -0.88 . . . . 0.0 109.403 179.989 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.436 ' HB ' ' CE1' ' A' ' 60' ' ' TYR . 1.7 p -77.37 149.2 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.228 -0.92 . . . . 0.0 109.809 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.447 HG22 ' N ' ' A' ' 6' ' ' ALA . 21.9 m -107.21 -32.77 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.342 -0.849 . . . . 0.0 109.222 179.747 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.447 ' N ' HG22 ' A' ' 5' ' ' VAL . . . -145.37 119.96 9.76 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.273 -0.892 . . . . 0.0 109.38 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 6.6 p -116.97 102.18 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.135 -0.978 . . . . 0.0 109.458 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.4 t -75.14 110.35 9.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.14 -0.975 . . . . 0.0 109.694 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 2.1 tmmt? -110.11 106.6 16.14 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 179.34 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.574 ' O ' ' N ' ' A' ' 55' ' ' VAL . 0.8 OUTLIER -151.21 174.42 13.27 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.02 -1.05 . . . . 0.0 110.286 -179.139 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.698 ' N ' ' NE2' ' A' ' 11' ' ' GLN . 0.0 OUTLIER -108.96 118.84 37.83 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.561 -0.712 . . . . 0.0 109.465 179.846 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -110.66 151.48 42.84 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.358 -0.839 . . . . 0.0 109.329 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -66.43 109.77 1.67 Allowed 'Trans proline' 0 C--N 1.313 -1.335 0 C-N-CA 121.614 1.543 . . . . 0.0 112.295 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.702 ' N ' ' O ' ' A' ' 51' ' ' ALA . . . -68.21 128.77 37.75 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.139 -0.976 . . . . 0.0 109.318 179.779 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.666 ' N ' ' OG1' ' A' ' 45' ' ' THR . . . 66.56 44.32 90.21 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.5 mtpm? 179.43 12.29 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.207 -1.172 . . . . 0.0 109.545 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -89.62 139.24 30.74 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.232 -0.917 . . . . 0.0 109.474 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.695 ' C ' ' H ' ' A' ' 20' ' ' ALA . 0.1 OUTLIER -119.31 159.72 44.35 Favored Pre-proline 0 N--CA 1.489 1.477 0 O-C-N 121.276 -0.89 . . . . 0.0 109.335 -179.842 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.432 ' HG3' ' SD ' ' A' ' 35' ' ' MET . 2.9 Cg_exo -51.05 14.72 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.691 0 C-N-CA 121.751 1.634 . . . . 0.0 113.094 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.695 ' H ' ' C ' ' A' ' 18' ' ' THR . . . -134.72 58.3 27.88 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.029 -1.044 . . . . 0.0 109.6 179.512 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.492 ' HD3' ' N ' ' A' ' 20' ' ' ALA . 6.0 Cg_endo -66.12 171.25 10.45 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 121.6 1.533 . . . . 0.0 112.357 179.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -58.58 -38.72 88.21 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 C-N-CA 121.521 1.481 . . . . 0.0 111.76 179.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.462 ' O ' ' HD2' ' A' ' 25' ' ' PRO . 61.3 t -78.27 -60.43 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.449 -0.782 . . . . 0.0 109.116 179.653 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 42.18 -98.46 0.01 OUTLIER Glycine 0 N--CA 1.495 2.611 0 N-CA-C 110.404 -1.078 . . . . 0.0 110.404 179.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.462 ' HD2' ' O ' ' A' ' 23' ' ' VAL . 11.4 Cg_exo -46.13 -34.16 12.83 Favored 'Trans proline' 0 C--N 1.315 -1.186 0 C-N-CA 121.194 1.262 . . . . 0.0 112.641 179.342 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -86.6 0.02 55.28 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.206 -0.934 . . . . 0.0 109.42 179.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.681 ' O ' ' N ' ' A' ' 29' ' ' GLN . 0.3 OUTLIER -104.82 -42.49 5.35 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.314 -0.866 . . . . 0.0 109.355 179.903 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -58.73 66.58 0.01 OUTLIER Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.74 -1.344 . . . . 0.0 109.74 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLN . . . . . 0.681 ' N ' ' O ' ' A' ' 27' ' ' LEU . 0.0 OUTLIER -133.52 20.32 3.94 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.287 -1.125 . . . . 0.0 109.369 179.9 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.464 ' ND1' ' CD2' ' A' ' 65' ' ' PHE . 0.6 OUTLIER -124.89 3.4 8.09 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.286 -0.884 . . . . 0.0 109.491 -179.887 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.498 ' O ' ' CB ' ' A' ' 32' ' ' ALA . . . 146.48 -1.24 0.84 Allowed Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.36 -1.496 . . . . 0.0 109.36 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.508 ' O ' ' OD1' ' A' ' 33' ' ' ASN . . . 74.59 68.82 0.09 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.29 -1.124 . . . . 0.0 109.43 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.508 ' OD1' ' O ' ' A' ' 32' ' ' ALA . 2.2 m-20 -142.44 83.58 1.83 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.249 -0.907 . . . . 0.0 109.554 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 6.1 mm -82.39 -38.93 15.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.229 -0.92 . . . . 0.0 109.421 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.615 ' O ' ' N ' ' A' ' 39' ' ' LYS . 8.5 tpt -63.82 -58.8 5.72 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.179 -0.951 . . . . 0.0 109.196 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.439 ' C ' ' O ' ' A' ' 35' ' ' MET . 3.6 mt-10 -44.75 -45.11 9.77 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.132 -0.98 . . . . 0.0 108.415 179.386 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.605 ' CE2' ' CD1' ' A' ' 27' ' ' LEU . 0.3 OUTLIER -54.87 -65.38 0.59 Allowed 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.982 -0.748 . . . . 0.0 108.982 179.314 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 21.6 t -69.87 -38.54 75.97 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.725 0 O-C-N 121.204 -0.935 . . . . 0.0 110.382 -179.219 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.615 ' N ' ' O ' ' A' ' 35' ' ' MET . 4.9 tttt -47.66 -64.42 0.79 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.93 -1.106 . . . . 0.0 108.546 179.157 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.404 ' O ' ' C ' ' A' ' 41' ' ' PHE . . . -57.93 -47.91 81.48 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 179.293 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.441 ' CE2' HG23 ' A' ' 45' ' ' THR . 14.8 t80 -45.5 -67.02 0.32 Allowed 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.262 -0.899 . . . . 0.0 108.655 179.321 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.665 ' O ' ' N ' ' A' ' 46' ' ' ALA . 5.2 m-20 -44.79 -47.69 10.91 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.386 -0.822 . . . . 0.0 108.876 179.54 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.442 ' C ' ' O ' ' A' ' 42' ' ' ASN . . . -44.53 -55.58 5.0 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.209 -0.932 . . . . 0.0 108.789 179.54 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.403 ' C ' ' H ' ' A' ' 46' ' ' ALA . . . -66.96 -62.81 1.25 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.274 -0.891 . . . . 0.0 109.208 179.421 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.666 ' OG1' ' N ' ' A' ' 15' ' ' GLY . 1.1 p -56.59 -10.89 1.09 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.507 -0.746 . . . . 0.0 109.5 -179.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.665 ' N ' ' O ' ' A' ' 42' ' ' ASN . . . -92.34 -36.34 13.23 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.234 -0.916 . . . . 0.0 109.075 179.474 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -76.95 -32.14 57.1 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.285 -0.884 . . . . 0.0 109.5 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' MET . . . . . 0.706 ' CG ' ' H ' ' A' ' 49' ' ' GLY . 0.4 OUTLIER -85.89 -69.17 0.68 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.178 -0.951 . . . . 0.0 109.485 -179.981 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.706 ' H ' ' CG ' ' A' ' 48' ' ' MET . . . 169.24 -158.01 30.24 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -100.31 147.87 25.3 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.251 -1.146 . . . . 0.0 109.477 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.702 ' O ' ' N ' ' A' ' 14' ' ' ALA . . . 174.85 -164.46 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.135 -0.978 . . . . 0.0 109.719 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.416 ' CG2' ' HB2' ' A' ' 11' ' ' GLN . 5.5 mm -127.07 133.96 67.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 179.285 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.561 ' CG1' ' OG1' ' A' ' 69' ' ' THR . 20.5 t -128.63 128.48 23.53 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 120.756 -1.215 . . . . 0.0 111.221 -178.604 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_endo -68.69 74.26 0.88 Allowed 'Trans proline' 0 N--CA 1.492 1.395 0 C-N-CA 121.423 1.415 . . . . 0.0 111.561 178.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.574 ' N ' ' O ' ' A' ' 10' ' ' LEU . 1.9 m -45.34 148.89 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.01 -1.056 . . . . 0.0 110.163 -179.047 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -137.52 62.33 1.58 Allowed 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 106.268 -1.752 . . . . 0.0 106.268 177.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 3.2 mt -65.25 99.77 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 CA-C-O 121.559 0.695 . . . . 0.0 110.332 -177.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.563 ' OG1' ' O ' ' A' ' 66' ' ' THR . 0.2 OUTLIER -82.06 102.11 10.8 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.586 -0.696 . . . . 0.0 109.501 -179.867 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 20.1 mt -90.66 113.81 27.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.382 -0.824 . . . . 0.0 109.389 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.436 ' CE1' ' HB ' ' A' ' 4' ' ' VAL . 2.6 m-85 -87.22 149.47 24.57 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.341 -0.849 . . . . 0.0 109.552 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.663 ' O ' ' N ' ' A' ' 63' ' ' ARG . . . -44.22 -48.14 9.32 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.566 -0.709 . . . . 0.0 109.641 -179.718 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.417 ' O ' ' C ' ' A' ' 63' ' ' ARG . 24.0 m-20 -62.63 37.63 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.126 -0.984 . . . . 0.0 109.121 179.773 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.663 ' N ' ' O ' ' A' ' 61' ' ' ALA . 44.1 mtt180 44.8 48.84 9.03 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.222 -0.924 . . . . 0.0 109.096 -179.698 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -115.45 125.25 52.87 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.254 -0.904 . . . . 0.0 109.892 -179.619 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.561 ' O ' ' CD1' ' A' ' 65' ' ' PHE . 41.5 p90 -110.86 127.99 55.62 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.366 -0.833 . . . . 0.0 109.313 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.563 ' O ' ' OG1' ' A' ' 58' ' ' THR . 4.5 p -137.98 133.85 34.16 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.096 -1.003 . . . . 0.0 110.076 -179.773 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.436 ' O ' ' CG2' ' A' ' 68' ' ' VAL . 27.7 p90 179.82 150.21 0.35 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.546 -0.722 . . . . 0.0 109.391 179.671 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.436 ' CG2' ' O ' ' A' ' 67' ' ' PHE . 88.6 t -156.21 84.66 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.253 -0.905 . . . . 0.0 109.427 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.561 ' OG1' ' CG1' ' A' ' 53' ' ' VAL . 1.2 t -120.79 138.4 54.04 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.231 -0.918 . . . . 0.0 109.275 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.706 ' O ' ' OG1' ' A' ' 71' ' ' THR . 0.0 OUTLIER -133.77 124.03 25.9 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.15 -0.969 . . . . 0.0 109.891 -179.713 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.706 ' OG1' ' O ' ' A' ' 70' ' ' LYS . 14.3 p 75.19 151.74 0.14 Allowed Pre-proline 0 N--CA 1.502 2.151 0 O-C-N 121.667 -0.646 . . . . 0.0 109.278 179.56 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.577 ' O ' ' O ' ' A' ' 71' ' ' THR . 13.2 Cg_exo -37.13 175.2 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.551 0 C-N-CA 122.395 2.063 . . . . 0.0 113.47 -179.222 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.698 ' O ' ' N ' ' A' ' 75' ' ' SER . 17.8 Cg_exo -49.25 169.75 0.1 OUTLIER 'Trans proline' 0 N--CA 1.493 1.449 0 C-N-CA 121.844 1.696 . . . . 0.0 113.182 -178.456 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.42 ' CB ' ' CB ' ' A' ' 130' ' ' SER . . . 62.5 -59.72 0.13 Allowed 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 -178.755 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.698 ' N ' ' O ' ' A' ' 73' ' ' PRO . 97.7 p -69.53 -22.5 63.57 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 179.053 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.606 ' CG ' ' N ' ' A' ' 77' ' ' LEU . 8.4 p90 -43.54 -50.09 7.27 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.634 -0.666 . . . . 0.0 110.001 -179.591 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.606 ' N ' ' CG ' ' A' ' 76' ' ' TYR . 0.1 OUTLIER -113.02 -30.66 6.93 Favored 'General case' 0 C--N 1.307 -1.252 0 O-C-N 121.491 -0.756 . . . . 0.0 109.771 -179.555 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . 0.539 ' O ' ' N ' ' A' ' 82' ' ' ALA . 34.2 mt -56.01 -38.29 52.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 120.832 -1.167 . . . . 0.0 108.891 179.821 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.545 ' NE ' ' CG2' ' A' ' 71' ' ' THR . 17.8 mmt180 -46.06 -71.82 0.07 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.024 -1.047 . . . . 0.0 108.448 179.239 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.467 ' HD3' ' N ' ' A' ' 81' ' ' ALA . 0.3 OUTLIER -47.77 -38.99 16.77 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.272 -0.893 . . . . 0.0 108.694 179.139 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.467 ' N ' ' HD3' ' A' ' 80' ' ' LYS . . . -66.12 -37.88 86.81 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.388 -0.82 . . . . 0.0 109.457 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.539 ' N ' ' O ' ' A' ' 78' ' ' ILE . . . -60.5 -26.53 66.9 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.195 -0.941 . . . . 0.0 109.323 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 126.87 -0.81 7.28 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.459 ' N ' HD21 ' A' ' 84' ' ' LEU . 5.7 mt -62.3 112.59 2.48 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.169 -1.195 . . . . 0.0 109.392 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.677 ' O ' ' N ' ' A' ' 87' ' ' GLY . 15.0 tt0 -159.76 -36.47 0.06 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.323 -0.861 . . . . 0.0 109.255 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.417 ' HB2' ' H ' ' A' ' 87' ' ' GLY . 45.1 mmtt 47.77 -81.08 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.354 -0.841 . . . . 0.0 109.806 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.677 ' N ' ' O ' ' A' ' 85' ' ' GLU . . . 102.35 -54.25 0.75 Allowed Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . 178.58 7.74 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.294 -1.121 . . . . 0.0 109.366 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 178.99 160.09 0.64 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.205 -0.934 . . . . 0.0 109.457 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.682 ' HZ3' ' CB ' ' A' ' 90' ' ' LYS . 0.0 OUTLIER -123.39 147.07 51.43 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.23 -0.919 . . . . 0.0 109.428 -179.735 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -62.16 -46.17 13.56 Favored 'Trans proline' 0 N--CA 1.491 1.324 0 C-N-CA 121.219 1.279 . . . . 0.0 112.196 179.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.579 ' O ' ' O ' ' A' ' 93' ' ' ARG . . . 128.57 143.36 5.58 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.715 ' CG ' HH11 ' A' ' 93' ' ' ARG . 0.0 OUTLIER 44.66 102.65 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.173 -1.192 . . . . 0.0 109.768 179.785 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -172.34 122.08 0.45 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.149 -0.969 . . . . 0.0 109.575 179.845 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 4.0 mtpp -73.15 99.73 2.89 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.157 -0.964 . . . . 0.0 109.377 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . 0.441 ' CG1' ' CD2' ' A' ' 84' ' ' LEU . 83.1 t -79.44 142.47 13.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.186 -0.946 . . . . 0.0 109.583 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.417 ' N ' HG13 ' A' ' 96' ' ' VAL . . . 106.15 56.14 0.66 Allowed Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 7.3 mtt180 -133.75 135.08 43.71 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.309 -1.112 . . . . 0.0 109.549 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.564 ' O ' ' N ' ' A' ' 139' ' ' VAL . 0.7 OUTLIER -128.57 172.77 14.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 179.623 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -127.99 150.37 49.94 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.033 -1.042 . . . . 0.0 109.532 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' TRP . . . . . 0.472 ' CD1' HD12 ' A' ' 105' ' ' LEU . 21.1 t-105 -46.45 -62.09 1.51 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.497 -0.752 . . . . 0.0 109.86 -179.797 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.517 ' O ' ' CD ' ' A' ' 102' ' ' GLU . 5.7 tp10 -43.47 -35.14 1.52 Allowed 'General case' 0 C--N 1.299 -1.61 0 O-C-N 120.965 -1.085 . . . . 0.0 109.666 -179.615 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -75.94 -51.89 11.46 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.264 -0.897 . . . . 0.0 110.401 -179.46 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.485 HG22 ' N ' ' A' ' 105' ' ' LEU . 2.3 m -57.04 -32.83 41.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 120.729 -1.232 . . . . 0.0 108.298 -179.35 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.485 ' N ' HG22 ' A' ' 104' ' ' VAL . 21.9 mt -68.9 -58.89 3.52 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 179.347 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 64.3 tt0 -48.79 -30.0 5.2 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.455 -0.942 . . . . 0.0 108.455 179.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.502 HG23 HD11 ' A' ' 107' ' ' ILE . 69.0 mt -81.12 -42.66 20.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.537 -0.727 . . . . 0.0 109.236 179.546 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.637 ' O ' ' N ' ' A' ' 111' ' ' LYS . . . -69.23 -51.3 39.05 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.174 -0.954 . . . . 0.0 109.839 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.423 ' C ' ' O ' ' A' ' 108' ' ' ALA . 36.8 mttt -44.58 -41.72 6.75 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.19 -0.944 . . . . 0.0 109.416 -179.72 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -81.73 2.41 29.96 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.21 -0.932 . . . . 0.0 109.214 179.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.637 ' N ' ' O ' ' A' ' 108' ' ' ALA . 20.6 tttm -117.03 2.81 12.73 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.28 -0.888 . . . . 0.0 109.751 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' MET . . . . . 0.592 ' SD ' ' CB ' ' A' ' 123' ' ' ALA . 10.3 ptm -134.71 58.79 31.1 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.122 -0.986 . . . . 0.0 109.886 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.468 ' HD3' ' N ' ' A' ' 112' ' ' MET . 1.8 Cg_endo -63.39 -42.49 21.71 Favored 'Trans proline' 0 C--N 1.306 -1.673 0 C-N-CA 121.56 1.507 . . . . 0.0 112.152 179.689 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -177.27 14.39 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.392 -0.817 . . . . 0.0 109.245 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -45.33 -81.62 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.361 -0.837 . . . . 0.0 109.696 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -155.07 -18.08 0.11 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.161 -0.962 . . . . 0.0 109.615 -179.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.762 ' CG2' ' H ' ' A' ' 118' ' ' THR . 19.0 m -74.2 -164.37 0.24 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.124 -0.985 . . . . 0.0 109.629 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.762 ' H ' ' CG2' ' A' ' 117' ' ' THR . 0.2 OUTLIER -166.25 -79.18 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.319 -0.863 . . . . 0.0 109.602 -179.36 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -60.38 145.47 47.8 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.331 -0.856 . . . . 0.0 109.744 -179.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.664 ' O ' ' N ' ' A' ' 124' ' ' ALA . 7.1 mt -62.57 -40.17 96.01 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.333 -0.854 . . . . 0.0 109.434 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.425 ' C ' ' O ' ' A' ' 120' ' ' LEU . 21.0 mt-10 -44.5 -59.38 2.47 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.221 -0.925 . . . . 0.0 109.36 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -50.49 -58.16 6.4 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.224 -0.923 . . . . 0.0 109.339 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . 0.592 ' CB ' ' SD ' ' A' ' 112' ' ' MET . . . -63.78 -56.59 14.35 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.299 -0.875 . . . . 0.0 109.197 179.726 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.664 ' N ' ' O ' ' A' ' 120' ' ' LEU . . . -44.47 -58.87 2.72 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.305 -0.872 . . . . 0.0 109.238 179.847 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . 0.474 ' O ' ' N ' ' A' ' 129' ' ' GLY . 8.4 ttt180 -49.59 -52.76 28.09 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.416 -0.803 . . . . 0.0 108.995 179.695 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.538 ' O ' ' OG ' ' A' ' 130' ' ' SER . 18.7 ttm -50.28 -36.98 33.79 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.219 -0.926 . . . . 0.0 108.845 179.462 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' ILE . . . . . 0.437 ' O ' ' C ' ' A' ' 128' ' ' ALA . 15.6 mm -76.25 -77.19 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.355 -0.841 . . . . 0.0 109.275 179.677 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.437 ' C ' ' O ' ' A' ' 127' ' ' ILE . . . -44.94 -32.66 1.7 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.247 -0.908 . . . . 0.0 108.628 179.638 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . 0.474 ' N ' ' O ' ' A' ' 125' ' ' ARG . . . -65.31 -61.07 6.02 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.013 -1.635 . . . . 0.0 109.013 179.564 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' SER . . . . . 0.538 ' OG ' ' O ' ' A' ' 126' ' ' MET . 4.8 m -45.03 -44.68 10.27 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.204 -1.174 . . . . 0.0 108.474 179.377 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -60.5 -46.79 88.82 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 179.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 2.4 tmt_? -49.78 -48.77 50.26 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.31 -0.869 . . . . 0.0 108.703 179.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.609 ' C ' ' H ' ' A' ' 135' ' ' GLY . 5.5 t -62.72 -35.81 80.94 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.337 -0.852 . . . . 0.0 108.714 179.349 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' MET . . . . . 0.619 ' O ' ' CG ' ' A' ' 134' ' ' MET . 8.3 ttp -68.78 23.2 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.436 -0.79 . . . . 0.0 109.284 179.641 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . 0.609 ' H ' ' C ' ' A' ' 133' ' ' SER . . . 66.85 -11.74 0.6 Allowed Glycine 0 N--CA 1.489 2.21 0 N-CA-C 108.525 -1.83 . . . . 0.0 108.525 -179.173 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.618 ' H ' ' C ' ' A' ' 134' ' ' MET . 24.7 t -69.88 156.95 6.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.53 -0.982 . . . . 0.0 109.56 179.763 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.437 ' N ' HG11 ' A' ' 136' ' ' VAL . 3.3 tt0 -127.92 145.48 50.94 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.25 -0.906 . . . . 0.0 109.577 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 1.9 t -77.67 99.5 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.254 -0.904 . . . . 0.0 109.328 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . 0.564 ' N ' ' O ' ' A' ' 99' ' ' ILE . 1.3 p -52.86 -39.95 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.278 -0.889 . . . . 0.0 109.579 -179.699 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' GLY . . . . . 0.509 ' N ' ' CG1' ' A' ' 139' ' ' VAL . . . -102.9 -146.66 17.7 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.968 -1.253 . . . . 0.0 109.968 -179.599 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . 0.472 ' N ' ' HD3' ' A' ' 142' ' ' PRO . . . 69.1 63.06 0.58 Allowed Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.367 -1.078 . . . . 0.0 109.329 -179.63 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' PRO . . . . . 0.472 ' HD3' ' N ' ' A' ' 141' ' ' ALA . 1.3 Cg_endo -65.56 128.4 20.07 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 C-N-CA 121.738 1.626 . . . . 0.0 112.608 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -76.42 67.78 2.67 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.228 -0.92 . . . . 0.0 109.316 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 3.1 m -79.41 94.38 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.274 -0.891 . . . . 0.0 109.569 -179.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 14.9 mttt -113.13 44.26 1.56 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.264 -0.898 . . . . 0.0 109.432 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . 0.515 ' OD1' ' N ' ' A' ' 147' ' ' ALA . 1.4 p30 -171.19 -37.72 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.212 -0.93 . . . . 0.0 109.588 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.515 ' N ' ' OD1' ' A' ' 146' ' ' ASP . . . . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 118.013 -0.994 . . . . 0.0 109.368 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.7 mtm . . . . . 0 N--CA 1.49 1.57 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -146.53 119.04 8.47 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.274 -0.891 . . . . 0.0 109.508 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -152.24 116.61 5.0 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.293 -0.88 . . . . 0.0 109.403 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.443 ' HB ' ' CE1' ' A' ' 60' ' ' TYR . 1.7 p -77.37 149.2 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.228 -0.92 . . . . 0.0 109.809 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.717 HG11 ' HB2' ' A' ' 61' ' ' ALA . 21.9 m -107.21 -32.77 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.342 -0.849 . . . . 0.0 109.222 179.747 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -145.37 119.96 9.76 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.273 -0.892 . . . . 0.0 109.38 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.626 ' O ' HG13 ' A' ' 7' ' ' VAL . 6.6 p -116.97 102.18 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.135 -0.978 . . . . 0.0 109.458 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.467 ' HB ' HD12 ' A' ' 57' ' ' ILE . 2.4 t -75.14 110.35 9.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.14 -0.975 . . . . 0.0 109.694 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.455 ' O ' HD12 ' A' ' 10' ' ' LEU . 2.1 tmmt? -110.11 106.6 16.14 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 179.34 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.608 ' O ' HG22 ' A' ' 55' ' ' VAL . 0.8 OUTLIER -151.21 174.42 13.27 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.02 -1.05 . . . . 0.0 110.286 -179.139 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.592 ' CD ' ' H ' ' A' ' 11' ' ' GLN . 2.2 pm0 -108.96 118.84 37.83 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.561 -0.712 . . . . 0.0 109.465 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.542 ' CD1' HG21 ' A' ' 55' ' ' VAL . 0.2 OUTLIER -110.66 151.48 42.84 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.358 -0.839 . . . . 0.0 109.329 -179.894 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.494 ' HA ' HD13 ' A' ' 52' ' ' ILE . 9.2 Cg_endo -66.43 109.77 1.67 Allowed 'Trans proline' 0 C--N 1.313 -1.335 0 C-N-CA 121.614 1.543 . . . . 0.0 112.295 179.788 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.702 ' N ' ' O ' ' A' ' 51' ' ' ALA . . . -68.21 128.77 37.75 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.139 -0.976 . . . . 0.0 109.318 179.779 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.666 ' N ' ' OG1' ' A' ' 45' ' ' THR . . . 66.56 44.32 90.21 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.5 mtpm? 179.43 12.29 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.207 -1.172 . . . . 0.0 109.545 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -89.62 139.24 30.74 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.232 -0.917 . . . . 0.0 109.474 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.672 ' O ' ' N ' ' A' ' 20' ' ' ALA . 0.1 OUTLIER -119.31 159.72 44.35 Favored Pre-proline 0 N--CA 1.489 1.477 0 O-C-N 121.276 -0.89 . . . . 0.0 109.335 -179.842 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.43 ' HG3' ' SD ' ' A' ' 35' ' ' MET . 2.9 Cg_exo -51.05 14.72 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.691 0 C-N-CA 121.751 1.634 . . . . 0.0 113.094 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.672 ' N ' ' O ' ' A' ' 18' ' ' THR . . . -134.72 58.3 27.88 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.029 -1.044 . . . . 0.0 109.6 179.512 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.509 ' HD3' ' N ' ' A' ' 20' ' ' ALA . 6.0 Cg_endo -66.12 171.25 10.45 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 121.6 1.533 . . . . 0.0 112.357 179.852 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -58.58 -38.72 88.21 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 C-N-CA 121.521 1.481 . . . . 0.0 111.76 179.412 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.951 HG13 ' HB3' ' A' ' 26' ' ' ALA . 61.3 t -78.27 -60.43 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.449 -0.782 . . . . 0.0 109.116 179.653 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 42.18 -98.46 0.01 OUTLIER Glycine 0 N--CA 1.495 2.611 0 N-CA-C 110.404 -1.078 . . . . 0.0 110.404 179.672 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.453 ' HD2' ' O ' ' A' ' 23' ' ' VAL . 11.4 Cg_exo -46.13 -34.16 12.83 Favored 'Trans proline' 0 C--N 1.315 -1.186 0 C-N-CA 121.194 1.262 . . . . 0.0 112.641 179.342 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.951 ' HB3' HG13 ' A' ' 23' ' ' VAL . . . -86.6 0.02 55.28 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.206 -0.934 . . . . 0.0 109.42 179.806 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.681 ' O ' ' N ' ' A' ' 29' ' ' GLN . 0.3 OUTLIER -104.82 -42.49 5.35 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.314 -0.866 . . . . 0.0 109.355 179.903 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -58.73 66.58 0.01 OUTLIER Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.74 -1.344 . . . . 0.0 109.74 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLN . . . . . 0.681 ' N ' ' O ' ' A' ' 27' ' ' LEU . 0.0 OUTLIER -133.52 20.32 3.94 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.287 -1.125 . . . . 0.0 109.369 179.9 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.493 ' ND1' ' CD2' ' A' ' 65' ' ' PHE . 0.6 OUTLIER -124.89 3.4 8.09 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.286 -0.884 . . . . 0.0 109.491 -179.887 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.689 ' O ' ' HB3' ' A' ' 32' ' ' ALA . . . 146.48 -1.24 0.84 Allowed Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.36 -1.496 . . . . 0.0 109.36 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.689 ' HB3' ' O ' ' A' ' 31' ' ' GLY . . . 74.59 68.82 0.09 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.29 -1.124 . . . . 0.0 109.43 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.508 ' OD1' ' O ' ' A' ' 32' ' ' ALA . 2.2 m-20 -142.44 83.58 1.83 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.249 -0.907 . . . . 0.0 109.554 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 6.1 mm -82.39 -38.93 15.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.229 -0.92 . . . . 0.0 109.421 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.564 ' O ' ' N ' ' A' ' 39' ' ' LYS . 8.5 tpt -63.82 -58.8 5.72 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.179 -0.951 . . . . 0.0 109.196 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.439 ' C ' ' O ' ' A' ' 35' ' ' MET . 3.6 mt-10 -44.75 -45.11 9.77 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.132 -0.98 . . . . 0.0 108.415 179.386 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.605 ' CE2' ' CD1' ' A' ' 27' ' ' LEU . 0.3 OUTLIER -54.87 -65.38 0.59 Allowed 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.982 -0.748 . . . . 0.0 108.982 179.314 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 21.6 t -69.87 -38.54 75.97 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.725 0 O-C-N 121.204 -0.935 . . . . 0.0 110.382 -179.219 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.564 ' N ' ' O ' ' A' ' 35' ' ' MET . 4.9 tttt -47.66 -64.42 0.79 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.93 -1.106 . . . . 0.0 108.546 179.157 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.578 ' O ' ' HB3' ' A' ' 43' ' ' ALA . . . -57.93 -47.91 81.48 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 179.293 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.654 ' O ' HG23 ' A' ' 45' ' ' THR . 14.8 t80 -45.5 -67.02 0.32 Allowed 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.262 -0.899 . . . . 0.0 108.655 179.321 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.665 ' O ' ' N ' ' A' ' 46' ' ' ALA . 5.2 m-20 -44.79 -47.69 10.91 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.386 -0.822 . . . . 0.0 108.876 179.54 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.578 ' HB3' ' O ' ' A' ' 40' ' ' ALA . . . -44.53 -55.58 5.0 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.209 -0.932 . . . . 0.0 108.789 179.54 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.43 ' HB1' ' HE2' ' A' ' 70' ' ' LYS . . . -66.96 -62.81 1.25 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.274 -0.891 . . . . 0.0 109.208 179.421 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.666 ' OG1' ' N ' ' A' ' 15' ' ' GLY . 1.1 p -56.59 -10.89 1.09 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.507 -0.746 . . . . 0.0 109.5 -179.785 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.665 ' N ' ' O ' ' A' ' 42' ' ' ASN . . . -92.34 -36.34 13.23 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.234 -0.916 . . . . 0.0 109.075 179.474 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -76.95 -32.14 57.1 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.285 -0.884 . . . . 0.0 109.5 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' MET . . . . . 0.659 ' CG ' ' H ' ' A' ' 49' ' ' GLY . 0.4 OUTLIER -85.89 -69.17 0.68 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.178 -0.951 . . . . 0.0 109.485 -179.981 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.659 ' H ' ' CG ' ' A' ' 48' ' ' MET . . . 169.24 -158.01 30.24 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.51 ' O ' ' HB2' ' A' ' 51' ' ' ALA . 5.7 p-10 -100.31 147.87 25.3 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.251 -1.146 . . . . 0.0 109.477 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.702 ' O ' ' N ' ' A' ' 14' ' ' ALA . . . 174.85 -164.46 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.135 -0.978 . . . . 0.0 109.719 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.494 HD13 ' HA ' ' A' ' 13' ' ' PRO . 5.5 mm -127.07 133.96 67.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 179.285 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.582 HG22 ' N ' ' A' ' 71' ' ' THR . 20.5 t -128.63 128.48 23.53 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 120.756 -1.215 . . . . 0.0 111.221 -178.604 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.455 ' HA ' ' O ' ' A' ' 10' ' ' LEU . 8.4 Cg_endo -68.69 74.26 0.88 Allowed 'Trans proline' 0 N--CA 1.492 1.395 0 C-N-CA 121.423 1.415 . . . . 0.0 111.561 178.252 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.608 HG22 ' O ' ' A' ' 10' ' ' LEU . 1.9 m -45.34 148.89 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.01 -1.056 . . . . 0.0 110.163 -179.047 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -137.52 62.33 1.58 Allowed 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 106.268 -1.752 . . . . 0.0 106.268 177.623 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.474 HD13 HD21 ' A' ' 27' ' ' LEU . 3.2 mt -65.25 99.77 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 CA-C-O 121.559 0.695 . . . . 0.0 110.332 -177.903 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.487 ' OG1' ' O ' ' A' ' 66' ' ' THR . 0.2 OUTLIER -82.06 102.11 10.8 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.586 -0.696 . . . . 0.0 109.501 -179.867 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 20.1 mt -90.66 113.81 27.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.382 -0.824 . . . . 0.0 109.389 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.493 ' N ' ' O ' ' A' ' 64' ' ' SER . 2.6 m-85 -87.22 149.47 24.57 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.341 -0.849 . . . . 0.0 109.552 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.717 ' HB2' HG11 ' A' ' 5' ' ' VAL . . . -44.22 -48.14 9.32 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.566 -0.709 . . . . 0.0 109.641 -179.718 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.417 ' O ' ' C ' ' A' ' 63' ' ' ARG . 24.0 m-20 -62.63 37.63 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.126 -0.984 . . . . 0.0 109.121 179.773 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.669 ' N ' ' O ' ' A' ' 61' ' ' ALA . 44.1 mtt180 44.8 48.84 9.03 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.222 -0.924 . . . . 0.0 109.096 -179.698 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.493 ' O ' ' N ' ' A' ' 60' ' ' TYR . 0.4 OUTLIER -115.45 125.25 52.87 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.254 -0.904 . . . . 0.0 109.892 -179.619 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.561 ' O ' ' CD1' ' A' ' 65' ' ' PHE . 41.5 p90 -110.86 127.99 55.62 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.366 -0.833 . . . . 0.0 109.313 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.487 ' O ' ' OG1' ' A' ' 58' ' ' THR . 4.5 p -137.98 133.85 34.16 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.096 -1.003 . . . . 0.0 110.076 -179.773 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.442 ' C ' HG23 ' A' ' 68' ' ' VAL . 27.7 p90 179.82 150.21 0.35 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.546 -0.722 . . . . 0.0 109.391 179.671 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.442 HG23 ' C ' ' A' ' 67' ' ' PHE . 88.6 t -156.21 84.66 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.253 -0.905 . . . . 0.0 109.427 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.561 ' OG1' ' CG1' ' A' ' 53' ' ' VAL . 1.2 t -120.79 138.4 54.04 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.231 -0.918 . . . . 0.0 109.275 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.706 ' O ' ' OG1' ' A' ' 71' ' ' THR . 0.0 OUTLIER -133.77 124.03 25.9 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.15 -0.969 . . . . 0.0 109.891 -179.713 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.848 HG21 ' NE ' ' A' ' 79' ' ' ARG . 14.3 p 75.19 151.74 0.14 Allowed Pre-proline 0 N--CA 1.502 2.151 0 O-C-N 121.667 -0.646 . . . . 0.0 109.278 179.56 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.577 ' O ' ' O ' ' A' ' 71' ' ' THR . 13.2 Cg_exo -37.13 175.2 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.551 0 C-N-CA 122.395 2.063 . . . . 0.0 113.47 -179.222 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.698 ' O ' ' N ' ' A' ' 75' ' ' SER . 17.8 Cg_exo -49.25 169.75 0.1 OUTLIER 'Trans proline' 0 N--CA 1.493 1.449 0 C-N-CA 121.844 1.696 . . . . 0.0 113.182 -178.456 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.455 ' HB3' ' O ' ' A' ' 73' ' ' PRO . . . 62.5 -59.72 0.13 Allowed 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 -178.755 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.698 ' N ' ' O ' ' A' ' 73' ' ' PRO . 97.7 p -69.53 -22.5 63.57 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 179.053 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.606 ' CG ' ' N ' ' A' ' 77' ' ' LEU . 8.4 p90 -43.54 -50.09 7.27 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.634 -0.666 . . . . 0.0 110.001 -179.591 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.902 HD23 ' N ' ' A' ' 78' ' ' ILE . 0.1 OUTLIER -113.02 -30.66 6.93 Favored 'General case' 0 C--N 1.307 -1.252 0 O-C-N 121.491 -0.756 . . . . 0.0 109.771 -179.555 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.902 ' N ' HD23 ' A' ' 77' ' ' LEU . 34.2 mt -56.01 -38.29 52.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 120.832 -1.167 . . . . 0.0 108.891 179.821 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.848 ' NE ' HG21 ' A' ' 71' ' ' THR . 17.8 mmt180 -46.06 -71.82 0.07 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.024 -1.047 . . . . 0.0 108.448 179.239 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.471 ' HD3' ' N ' ' A' ' 81' ' ' ALA . 0.3 OUTLIER -47.77 -38.99 16.77 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.272 -0.893 . . . . 0.0 108.694 179.139 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.471 ' N ' ' HD3' ' A' ' 80' ' ' LYS . . . -66.12 -37.88 86.81 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.388 -0.82 . . . . 0.0 109.457 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.552 ' N ' ' O ' ' A' ' 78' ' ' ILE . . . -60.5 -26.53 66.9 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.195 -0.941 . . . . 0.0 109.323 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 126.87 -0.81 7.28 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.624 HD12 ' HB3' ' A' ' 79' ' ' ARG . 5.7 mt -62.3 112.59 2.48 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.169 -1.195 . . . . 0.0 109.392 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.677 ' O ' ' N ' ' A' ' 87' ' ' GLY . 15.0 tt0 -159.76 -36.47 0.06 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.323 -0.861 . . . . 0.0 109.255 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 45.1 mmtt 47.77 -81.08 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.354 -0.841 . . . . 0.0 109.806 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.677 ' N ' ' O ' ' A' ' 85' ' ' GLU . . . 102.35 -54.25 0.75 Allowed Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.417 ' HB2' ' O ' ' A' ' 87' ' ' GLY . . . 178.58 7.74 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.294 -1.121 . . . . 0.0 109.366 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 178.99 160.09 0.64 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.205 -0.934 . . . . 0.0 109.457 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.478 ' CB ' ' HZ3' ' A' ' 90' ' ' LYS . 0.0 OUTLIER -123.39 147.07 51.43 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.23 -0.919 . . . . 0.0 109.428 -179.735 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -62.16 -46.17 13.56 Favored 'Trans proline' 0 N--CA 1.491 1.324 0 C-N-CA 121.219 1.279 . . . . 0.0 112.196 179.583 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.579 ' O ' ' O ' ' A' ' 93' ' ' ARG . . . 128.57 143.36 5.58 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.728 HH11 ' CG ' ' A' ' 93' ' ' ARG . 0.0 OUTLIER 44.66 102.65 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.173 -1.192 . . . . 0.0 109.768 179.785 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -172.34 122.08 0.45 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.149 -0.969 . . . . 0.0 109.575 179.845 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 4.0 mtpp -73.15 99.73 2.89 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.157 -0.964 . . . . 0.0 109.377 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' VAL . . . . . 0.441 ' CG1' ' CD2' ' A' ' 84' ' ' LEU . 83.1 t -79.44 142.47 13.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.186 -0.946 . . . . 0.0 109.583 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 106.15 56.14 0.66 Allowed Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 7.3 mtt180 -133.75 135.08 43.71 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.309 -1.112 . . . . 0.0 109.549 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.601 HD13 HG12 ' A' ' 104' ' ' VAL . 0.7 OUTLIER -128.57 172.77 14.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 179.623 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.685 HG22 ' CG1' ' A' ' 139' ' ' VAL . 0.5 OUTLIER -127.99 150.37 49.94 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.033 -1.042 . . . . 0.0 109.532 -179.855 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 101' ' ' TRP . . . . . 0.714 ' CH2' ' HB1' ' A' ' 124' ' ' ALA . 21.1 t-105 -46.45 -62.09 1.51 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.497 -0.752 . . . . 0.0 109.86 -179.797 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.517 ' CD ' ' O ' ' A' ' 102' ' ' GLU . 5.7 tp10 -43.47 -35.14 1.52 Allowed 'General case' 0 C--N 1.299 -1.61 0 O-C-N 120.965 -1.085 . . . . 0.0 109.666 -179.615 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -75.94 -51.89 11.46 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.264 -0.897 . . . . 0.0 110.401 -179.46 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.601 HG12 HD13 ' A' ' 99' ' ' ILE . 2.3 m -57.04 -32.83 41.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 120.729 -1.232 . . . . 0.0 108.298 -179.35 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.562 HD11 ' NE1' ' A' ' 101' ' ' TRP . 21.9 mt -68.9 -58.89 3.52 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 179.347 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 64.3 tt0 -48.79 -30.0 5.2 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.455 -0.942 . . . . 0.0 108.455 179.227 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.552 HD13 ' CD2' ' A' ' 77' ' ' LEU . 69.0 mt -81.12 -42.66 20.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.537 -0.727 . . . . 0.0 109.236 179.546 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.816 ' HB2' HG13 ' A' ' 127' ' ' ILE . . . -69.23 -51.3 39.05 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.174 -0.954 . . . . 0.0 109.839 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.789 ' HE2' HD11 ' A' ' 120' ' ' LEU . 36.8 mttt -44.58 -41.72 6.75 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.19 -0.944 . . . . 0.0 109.416 -179.72 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 4.1 mt-30 -81.73 2.41 29.96 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.21 -0.932 . . . . 0.0 109.214 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.556 ' N ' ' O ' ' A' ' 108' ' ' ALA . 20.6 tttm -117.03 2.81 12.73 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.28 -0.888 . . . . 0.0 109.751 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' MET . . . . . 0.592 ' SD ' ' CB ' ' A' ' 123' ' ' ALA . 10.3 ptm -134.71 58.79 31.1 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.122 -0.986 . . . . 0.0 109.886 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.488 ' HD3' ' N ' ' A' ' 112' ' ' MET . 1.8 Cg_endo -63.39 -42.49 21.71 Favored 'Trans proline' 0 C--N 1.306 -1.673 0 C-N-CA 121.56 1.507 . . . . 0.0 112.152 179.689 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -177.27 14.39 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.392 -0.817 . . . . 0.0 109.245 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -45.33 -81.62 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.361 -0.837 . . . . 0.0 109.696 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -155.07 -18.08 0.11 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.161 -0.962 . . . . 0.0 109.615 -179.749 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' THR . . . . . 1.15 HG22 ' H ' ' A' ' 118' ' ' THR . 19.0 m -74.2 -164.37 0.24 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.124 -0.985 . . . . 0.0 109.629 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' THR . . . . . 1.15 ' H ' HG22 ' A' ' 117' ' ' THR . 0.2 OUTLIER -166.25 -79.18 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.319 -0.863 . . . . 0.0 109.602 -179.36 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ASP . . . . . 0.516 ' H ' HG23 ' A' ' 118' ' ' THR . 1.0 OUTLIER -60.38 145.47 47.8 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.331 -0.856 . . . . 0.0 109.744 -179.823 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.789 HD11 ' HE2' ' A' ' 109' ' ' LYS . 7.1 mt -62.57 -40.17 96.01 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.333 -0.854 . . . . 0.0 109.434 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.425 ' C ' ' O ' ' A' ' 120' ' ' LEU . 21.0 mt-10 -44.5 -59.38 2.47 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.221 -0.925 . . . . 0.0 109.36 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -50.49 -58.16 6.4 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.224 -0.923 . . . . 0.0 109.339 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.592 ' CB ' ' SD ' ' A' ' 112' ' ' MET . . . -63.78 -56.59 14.35 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.299 -0.875 . . . . 0.0 109.197 179.726 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.714 ' HB1' ' CH2' ' A' ' 101' ' ' TRP . . . -44.47 -58.87 2.72 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.305 -0.872 . . . . 0.0 109.238 179.847 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ARG . . . . . 0.474 ' O ' ' N ' ' A' ' 129' ' ' GLY . 8.4 ttt180 -49.59 -52.76 28.09 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.416 -0.803 . . . . 0.0 108.995 179.695 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.501 ' O ' ' OG ' ' A' ' 130' ' ' SER . 18.7 ttm -50.28 -36.98 33.79 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.219 -0.926 . . . . 0.0 108.845 179.462 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' ILE . . . . . 0.816 HG13 ' HB2' ' A' ' 108' ' ' ALA . 15.6 mm -76.25 -77.19 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.355 -0.841 . . . . 0.0 109.275 179.677 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.437 ' C ' ' O ' ' A' ' 127' ' ' ILE . . . -44.94 -32.66 1.7 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.247 -0.908 . . . . 0.0 108.628 179.638 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' GLY . . . . . 0.474 ' N ' ' O ' ' A' ' 125' ' ' ARG . . . -65.31 -61.07 6.02 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.013 -1.635 . . . . 0.0 109.013 179.564 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' SER . . . . . 0.501 ' OG ' ' O ' ' A' ' 126' ' ' MET . 4.8 m -45.03 -44.68 10.27 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.204 -1.174 . . . . 0.0 108.474 179.377 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -60.5 -46.79 88.82 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 179.221 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 2.4 tmt_? -49.78 -48.77 50.26 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.31 -0.869 . . . . 0.0 108.703 179.382 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.568 ' C ' ' H ' ' A' ' 135' ' ' GLY . 5.5 t -62.72 -35.81 80.94 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.337 -0.852 . . . . 0.0 108.714 179.349 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' MET . . . . . 0.621 ' HG2' HG23 ' A' ' 136' ' ' VAL . 8.3 ttp -68.78 23.2 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.436 -0.79 . . . . 0.0 109.284 179.641 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.568 ' H ' ' C ' ' A' ' 133' ' ' SER . . . 66.85 -11.74 0.6 Allowed Glycine 0 N--CA 1.489 2.21 0 N-CA-C 108.525 -1.83 . . . . 0.0 108.525 -179.173 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.621 HG23 ' HG2' ' A' ' 134' ' ' MET . 24.7 t -69.88 156.95 6.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.53 -0.982 . . . . 0.0 109.56 179.763 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.409 ' N ' ' CG1' ' A' ' 136' ' ' VAL . 3.3 tt0 -127.92 145.48 50.94 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.25 -0.906 . . . . 0.0 109.577 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 1.9 t -77.67 99.5 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.254 -0.904 . . . . 0.0 109.328 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.685 ' CG1' HG22 ' A' ' 100' ' ' THR . 1.3 p -52.86 -39.95 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.278 -0.889 . . . . 0.0 109.579 -179.699 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' GLY . . . . . 0.578 ' O ' ' HB3' ' A' ' 141' ' ' ALA . . . -102.9 -146.66 17.7 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.968 -1.253 . . . . 0.0 109.968 -179.599 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.578 ' HB3' ' O ' ' A' ' 140' ' ' GLY . . . 69.1 63.06 0.58 Allowed Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.367 -1.078 . . . . 0.0 109.329 -179.63 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' PRO . . . . . 0.482 ' HD3' ' N ' ' A' ' 141' ' ' ALA . 1.3 Cg_endo -65.56 128.4 20.07 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 C-N-CA 121.738 1.626 . . . . 0.0 112.608 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -76.42 67.78 2.67 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.228 -0.92 . . . . 0.0 109.316 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.437 ' H ' HG22 ' A' ' 144' ' ' VAL . 3.1 m -79.41 94.38 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.274 -0.891 . . . . 0.0 109.569 -179.8 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 14.9 mttt -113.13 44.26 1.56 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.264 -0.898 . . . . 0.0 109.432 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' ASP . . . . . 0.515 ' OD1' ' N ' ' A' ' 147' ' ' ALA . 1.4 p30 -171.19 -37.72 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.212 -0.93 . . . . 0.0 109.588 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.515 ' N ' ' OD1' ' A' ' 146' ' ' ASP . . . . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 118.013 -0.994 . . . . 0.0 109.368 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.7 mtm . . . . . 0 N--CA 1.49 1.57 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -146.53 119.04 8.47 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.274 -0.891 . . . . 0.0 109.508 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -152.24 116.61 5.0 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.293 -0.88 . . . . 0.0 109.403 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.443 ' HB ' ' CE1' ' A' ' 60' ' ' TYR . 1.7 p -77.37 149.2 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.228 -0.92 . . . . 0.0 109.809 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.717 HG11 ' HB2' ' A' ' 61' ' ' ALA . 21.9 m -107.21 -32.77 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.342 -0.849 . . . . 0.0 109.222 179.747 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -145.37 119.96 9.76 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.273 -0.892 . . . . 0.0 109.38 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.626 ' O ' HG13 ' A' ' 7' ' ' VAL . 6.6 p -116.97 102.18 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.135 -0.978 . . . . 0.0 109.458 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.467 ' HB ' HD12 ' A' ' 57' ' ' ILE . 2.4 t -75.14 110.35 9.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.14 -0.975 . . . . 0.0 109.694 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.455 ' O ' HD12 ' A' ' 10' ' ' LEU . 2.1 tmmt? -110.11 106.6 16.14 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 179.34 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.608 ' O ' HG22 ' A' ' 55' ' ' VAL . 0.8 OUTLIER -151.21 174.42 13.27 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.02 -1.05 . . . . 0.0 110.286 -179.139 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.698 ' N ' ' NE2' ' A' ' 11' ' ' GLN . 0.0 OUTLIER -108.96 118.84 37.83 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.561 -0.712 . . . . 0.0 109.465 179.846 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.542 ' CD1' HG21 ' A' ' 55' ' ' VAL . 0.2 OUTLIER -110.66 151.48 42.84 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.358 -0.839 . . . . 0.0 109.329 -179.894 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.494 ' HA ' HD13 ' A' ' 52' ' ' ILE . 9.2 Cg_endo -66.43 109.77 1.67 Allowed 'Trans proline' 0 C--N 1.313 -1.335 0 C-N-CA 121.614 1.543 . . . . 0.0 112.295 179.788 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.702 ' N ' ' O ' ' A' ' 51' ' ' ALA . . . -68.21 128.77 37.75 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.139 -0.976 . . . . 0.0 109.318 179.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.666 ' N ' ' OG1' ' A' ' 45' ' ' THR . . . 66.56 44.32 90.21 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.5 mtpm? 179.43 12.29 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.207 -1.172 . . . . 0.0 109.545 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -89.62 139.24 30.74 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.232 -0.917 . . . . 0.0 109.474 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.672 ' O ' ' N ' ' A' ' 20' ' ' ALA . 0.1 OUTLIER -119.31 159.72 44.35 Favored Pre-proline 0 N--CA 1.489 1.477 0 O-C-N 121.276 -0.89 . . . . 0.0 109.335 -179.842 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.43 ' HG3' ' SD ' ' A' ' 35' ' ' MET . 2.9 Cg_exo -51.05 14.72 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.691 0 C-N-CA 121.751 1.634 . . . . 0.0 113.094 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.672 ' N ' ' O ' ' A' ' 18' ' ' THR . . . -134.72 58.3 27.88 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.029 -1.044 . . . . 0.0 109.6 179.512 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.509 ' HD3' ' N ' ' A' ' 20' ' ' ALA . 6.0 Cg_endo -66.12 171.25 10.45 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 121.6 1.533 . . . . 0.0 112.357 179.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -58.58 -38.72 88.21 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 C-N-CA 121.521 1.481 . . . . 0.0 111.76 179.412 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.951 HG13 ' HB3' ' A' ' 26' ' ' ALA . 61.3 t -78.27 -60.43 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.449 -0.782 . . . . 0.0 109.116 179.653 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 42.18 -98.46 0.01 OUTLIER Glycine 0 N--CA 1.495 2.611 0 N-CA-C 110.404 -1.078 . . . . 0.0 110.404 179.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.453 ' HD2' ' O ' ' A' ' 23' ' ' VAL . 11.4 Cg_exo -46.13 -34.16 12.83 Favored 'Trans proline' 0 C--N 1.315 -1.186 0 C-N-CA 121.194 1.262 . . . . 0.0 112.641 179.342 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.951 ' HB3' HG13 ' A' ' 23' ' ' VAL . . . -86.6 0.02 55.28 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.206 -0.934 . . . . 0.0 109.42 179.806 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.681 ' O ' ' N ' ' A' ' 29' ' ' GLN . 0.3 OUTLIER -104.82 -42.49 5.35 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.314 -0.866 . . . . 0.0 109.355 179.903 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -58.73 66.58 0.01 OUTLIER Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.74 -1.344 . . . . 0.0 109.74 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLN . . . . . 0.681 ' N ' ' O ' ' A' ' 27' ' ' LEU . 0.0 OUTLIER -133.52 20.32 3.94 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.287 -1.125 . . . . 0.0 109.369 179.9 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.493 ' ND1' ' CD2' ' A' ' 65' ' ' PHE . 0.6 OUTLIER -124.89 3.4 8.09 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.286 -0.884 . . . . 0.0 109.491 -179.887 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.689 ' O ' ' HB3' ' A' ' 32' ' ' ALA . . . 146.48 -1.24 0.84 Allowed Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.36 -1.496 . . . . 0.0 109.36 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.689 ' HB3' ' O ' ' A' ' 31' ' ' GLY . . . 74.59 68.82 0.09 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.29 -1.124 . . . . 0.0 109.43 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.508 ' OD1' ' O ' ' A' ' 32' ' ' ALA . 2.2 m-20 -142.44 83.58 1.83 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.249 -0.907 . . . . 0.0 109.554 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 6.1 mm -82.39 -38.93 15.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.229 -0.92 . . . . 0.0 109.421 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.564 ' O ' ' N ' ' A' ' 39' ' ' LYS . 8.5 tpt -63.82 -58.8 5.72 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.179 -0.951 . . . . 0.0 109.196 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.439 ' C ' ' O ' ' A' ' 35' ' ' MET . 3.6 mt-10 -44.75 -45.11 9.77 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.132 -0.98 . . . . 0.0 108.415 179.386 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.605 ' CE2' ' CD1' ' A' ' 27' ' ' LEU . 0.3 OUTLIER -54.87 -65.38 0.59 Allowed 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.982 -0.748 . . . . 0.0 108.982 179.314 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 21.6 t -69.87 -38.54 75.97 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.725 0 O-C-N 121.204 -0.935 . . . . 0.0 110.382 -179.219 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.564 ' N ' ' O ' ' A' ' 35' ' ' MET . 4.9 tttt -47.66 -64.42 0.79 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.93 -1.106 . . . . 0.0 108.546 179.157 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.578 ' O ' ' HB3' ' A' ' 43' ' ' ALA . . . -57.93 -47.91 81.48 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 179.293 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.654 ' O ' HG23 ' A' ' 45' ' ' THR . 14.8 t80 -45.5 -67.02 0.32 Allowed 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.262 -0.899 . . . . 0.0 108.655 179.321 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.665 ' O ' ' N ' ' A' ' 46' ' ' ALA . 5.2 m-20 -44.79 -47.69 10.91 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.386 -0.822 . . . . 0.0 108.876 179.54 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.578 ' HB3' ' O ' ' A' ' 40' ' ' ALA . . . -44.53 -55.58 5.0 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.209 -0.932 . . . . 0.0 108.789 179.54 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.43 ' HB1' ' HE2' ' A' ' 70' ' ' LYS . . . -66.96 -62.81 1.25 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.274 -0.891 . . . . 0.0 109.208 179.421 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.666 ' OG1' ' N ' ' A' ' 15' ' ' GLY . 1.1 p -56.59 -10.89 1.09 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.507 -0.746 . . . . 0.0 109.5 -179.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.665 ' N ' ' O ' ' A' ' 42' ' ' ASN . . . -92.34 -36.34 13.23 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.234 -0.916 . . . . 0.0 109.075 179.474 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -76.95 -32.14 57.1 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.285 -0.884 . . . . 0.0 109.5 179.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . 0.659 ' CG ' ' H ' ' A' ' 49' ' ' GLY . 0.4 OUTLIER -85.89 -69.17 0.68 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.178 -0.951 . . . . 0.0 109.485 -179.981 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.659 ' H ' ' CG ' ' A' ' 48' ' ' MET . . . 169.24 -158.01 30.24 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.51 ' O ' ' HB2' ' A' ' 51' ' ' ALA . 5.7 p-10 -100.31 147.87 25.3 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.251 -1.146 . . . . 0.0 109.477 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.702 ' O ' ' N ' ' A' ' 14' ' ' ALA . . . 174.85 -164.46 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.135 -0.978 . . . . 0.0 109.719 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.494 HD13 ' HA ' ' A' ' 13' ' ' PRO . 5.5 mm -127.07 133.96 67.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 179.285 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.582 HG22 ' N ' ' A' ' 71' ' ' THR . 20.5 t -128.63 128.48 23.53 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 120.756 -1.215 . . . . 0.0 111.221 -178.604 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.455 ' HA ' ' O ' ' A' ' 10' ' ' LEU . 8.4 Cg_endo -68.69 74.26 0.88 Allowed 'Trans proline' 0 N--CA 1.492 1.395 0 C-N-CA 121.423 1.415 . . . . 0.0 111.561 178.252 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.608 HG22 ' O ' ' A' ' 10' ' ' LEU . 1.9 m -45.34 148.89 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.01 -1.056 . . . . 0.0 110.163 -179.047 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -137.52 62.33 1.58 Allowed 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 106.268 -1.752 . . . . 0.0 106.268 177.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.474 HD13 HD21 ' A' ' 27' ' ' LEU . 3.2 mt -65.25 99.77 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 CA-C-O 121.559 0.695 . . . . 0.0 110.332 -177.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.487 ' OG1' ' O ' ' A' ' 66' ' ' THR . 0.2 OUTLIER -82.06 102.11 10.8 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.586 -0.696 . . . . 0.0 109.501 -179.867 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 20.1 mt -90.66 113.81 27.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.382 -0.824 . . . . 0.0 109.389 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.493 ' N ' ' O ' ' A' ' 64' ' ' SER . 2.6 m-85 -87.22 149.47 24.57 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.341 -0.849 . . . . 0.0 109.552 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.717 ' HB2' HG11 ' A' ' 5' ' ' VAL . . . -44.22 -48.14 9.32 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.566 -0.709 . . . . 0.0 109.641 -179.718 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.417 ' O ' ' C ' ' A' ' 63' ' ' ARG . 24.0 m-20 -62.63 37.63 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.126 -0.984 . . . . 0.0 109.121 179.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.669 ' N ' ' O ' ' A' ' 61' ' ' ALA . 44.1 mtt180 44.8 48.84 9.03 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.222 -0.924 . . . . 0.0 109.096 -179.698 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.493 ' O ' ' N ' ' A' ' 60' ' ' TYR . 0.4 OUTLIER -115.45 125.25 52.87 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.254 -0.904 . . . . 0.0 109.892 -179.619 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.561 ' O ' ' CD1' ' A' ' 65' ' ' PHE . 41.5 p90 -110.86 127.99 55.62 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.366 -0.833 . . . . 0.0 109.313 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.487 ' O ' ' OG1' ' A' ' 58' ' ' THR . 4.5 p -137.98 133.85 34.16 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.096 -1.003 . . . . 0.0 110.076 -179.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.442 ' C ' HG23 ' A' ' 68' ' ' VAL . 27.7 p90 179.82 150.21 0.35 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.546 -0.722 . . . . 0.0 109.391 179.671 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.442 HG23 ' C ' ' A' ' 67' ' ' PHE . 88.6 t -156.21 84.66 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.253 -0.905 . . . . 0.0 109.427 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.561 ' OG1' ' CG1' ' A' ' 53' ' ' VAL . 1.2 t -120.79 138.4 54.04 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.231 -0.918 . . . . 0.0 109.275 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.706 ' O ' ' OG1' ' A' ' 71' ' ' THR . 0.0 OUTLIER -133.77 124.03 25.9 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.15 -0.969 . . . . 0.0 109.891 -179.713 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.848 HG21 ' NE ' ' A' ' 79' ' ' ARG . 14.3 p 75.19 151.74 0.14 Allowed Pre-proline 0 N--CA 1.502 2.151 0 O-C-N 121.667 -0.646 . . . . 0.0 109.278 179.56 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.577 ' O ' ' O ' ' A' ' 71' ' ' THR . 13.2 Cg_exo -37.13 175.2 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.551 0 C-N-CA 122.395 2.063 . . . . 0.0 113.47 -179.222 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.698 ' O ' ' N ' ' A' ' 75' ' ' SER . 17.8 Cg_exo -49.25 169.75 0.1 OUTLIER 'Trans proline' 0 N--CA 1.493 1.449 0 C-N-CA 121.844 1.696 . . . . 0.0 113.182 -178.456 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.455 ' HB3' ' O ' ' A' ' 73' ' ' PRO . . . 62.5 -59.72 0.13 Allowed 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 -178.755 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.698 ' N ' ' O ' ' A' ' 73' ' ' PRO . 97.7 p -69.53 -22.5 63.57 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 179.053 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.606 ' CG ' ' N ' ' A' ' 77' ' ' LEU . 8.4 p90 -43.54 -50.09 7.27 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.634 -0.666 . . . . 0.0 110.001 -179.591 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.902 HD23 ' N ' ' A' ' 78' ' ' ILE . 0.1 OUTLIER -113.02 -30.66 6.93 Favored 'General case' 0 C--N 1.307 -1.252 0 O-C-N 121.491 -0.756 . . . . 0.0 109.771 -179.555 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.902 ' N ' HD23 ' A' ' 77' ' ' LEU . 34.2 mt -56.01 -38.29 52.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 120.832 -1.167 . . . . 0.0 108.891 179.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.848 ' NE ' HG21 ' A' ' 71' ' ' THR . 17.8 mmt180 -46.06 -71.82 0.07 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.024 -1.047 . . . . 0.0 108.448 179.239 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.471 ' HD3' ' N ' ' A' ' 81' ' ' ALA . 0.3 OUTLIER -47.77 -38.99 16.77 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.272 -0.893 . . . . 0.0 108.694 179.139 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.471 ' N ' ' HD3' ' A' ' 80' ' ' LYS . . . -66.12 -37.88 86.81 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.388 -0.82 . . . . 0.0 109.457 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.552 ' N ' ' O ' ' A' ' 78' ' ' ILE . . . -60.5 -26.53 66.9 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.195 -0.941 . . . . 0.0 109.323 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 126.87 -0.81 7.28 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.624 HD12 ' HB3' ' A' ' 79' ' ' ARG . 5.7 mt -62.3 112.59 2.48 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.169 -1.195 . . . . 0.0 109.392 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.677 ' O ' ' N ' ' A' ' 87' ' ' GLY . 15.0 tt0 -159.76 -36.47 0.06 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.323 -0.861 . . . . 0.0 109.255 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 45.1 mmtt 47.77 -81.08 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.354 -0.841 . . . . 0.0 109.806 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.677 ' N ' ' O ' ' A' ' 85' ' ' GLU . . . 102.35 -54.25 0.75 Allowed Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.417 ' HB2' ' O ' ' A' ' 87' ' ' GLY . . . 178.58 7.74 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.294 -1.121 . . . . 0.0 109.366 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 178.99 160.09 0.64 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.205 -0.934 . . . . 0.0 109.457 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.478 ' HZ3' ' CB ' ' A' ' 90' ' ' LYS . 0.0 OUTLIER -123.39 147.07 51.43 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.23 -0.919 . . . . 0.0 109.428 -179.735 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -62.16 -46.17 13.56 Favored 'Trans proline' 0 N--CA 1.491 1.324 0 C-N-CA 121.219 1.279 . . . . 0.0 112.196 179.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.579 ' O ' ' O ' ' A' ' 93' ' ' ARG . . . 128.57 143.36 5.58 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.728 ' CG ' HH11 ' A' ' 93' ' ' ARG . 0.0 OUTLIER 44.66 102.65 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.173 -1.192 . . . . 0.0 109.768 179.785 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -172.34 122.08 0.45 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.149 -0.969 . . . . 0.0 109.575 179.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 4.0 mtpp -73.15 99.73 2.89 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.157 -0.964 . . . . 0.0 109.377 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . 0.441 ' CG1' ' CD2' ' A' ' 84' ' ' LEU . 83.1 t -79.44 142.47 13.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.186 -0.946 . . . . 0.0 109.583 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 106.15 56.14 0.66 Allowed Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 7.3 mtt180 -133.75 135.08 43.71 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.309 -1.112 . . . . 0.0 109.549 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.601 HD13 HG12 ' A' ' 104' ' ' VAL . 0.7 OUTLIER -128.57 172.77 14.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 N-CA-C 108.636 -0.875 . . . . 0.0 108.636 179.623 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.685 HG22 ' CG1' ' A' ' 139' ' ' VAL . 0.5 OUTLIER -127.99 150.37 49.94 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.033 -1.042 . . . . 0.0 109.532 -179.855 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' TRP . . . . . 0.714 ' CH2' ' HB1' ' A' ' 124' ' ' ALA . 21.1 t-105 -46.45 -62.09 1.51 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.497 -0.752 . . . . 0.0 109.86 -179.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.517 ' O ' ' CD ' ' A' ' 102' ' ' GLU . 5.7 tp10 -43.47 -35.14 1.52 Allowed 'General case' 0 C--N 1.299 -1.61 0 O-C-N 120.965 -1.085 . . . . 0.0 109.666 -179.615 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -75.94 -51.89 11.46 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.264 -0.897 . . . . 0.0 110.401 -179.46 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.601 HG12 HD13 ' A' ' 99' ' ' ILE . 2.3 m -57.04 -32.83 41.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 120.729 -1.232 . . . . 0.0 108.298 -179.35 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.562 HD11 ' NE1' ' A' ' 101' ' ' TRP . 21.9 mt -68.9 -58.89 3.52 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 179.347 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 64.3 tt0 -48.79 -30.0 5.2 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.455 -0.942 . . . . 0.0 108.455 179.227 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.552 HD13 ' CD2' ' A' ' 77' ' ' LEU . 69.0 mt -81.12 -42.66 20.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.537 -0.727 . . . . 0.0 109.236 179.546 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.816 ' HB2' HG13 ' A' ' 127' ' ' ILE . . . -69.23 -51.3 39.05 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.174 -0.954 . . . . 0.0 109.839 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.789 ' HE2' HD11 ' A' ' 120' ' ' LEU . 36.8 mttt -44.58 -41.72 6.75 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.19 -0.944 . . . . 0.0 109.416 -179.72 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -81.73 2.41 29.96 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.21 -0.932 . . . . 0.0 109.214 179.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.556 ' N ' ' O ' ' A' ' 108' ' ' ALA . 20.6 tttm -117.03 2.81 12.73 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.28 -0.888 . . . . 0.0 109.751 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . 0.592 ' SD ' ' CB ' ' A' ' 123' ' ' ALA . 10.3 ptm -134.71 58.79 31.1 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.122 -0.986 . . . . 0.0 109.886 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.488 ' HD3' ' N ' ' A' ' 112' ' ' MET . 1.8 Cg_endo -63.39 -42.49 21.71 Favored 'Trans proline' 0 C--N 1.306 -1.673 0 C-N-CA 121.56 1.507 . . . . 0.0 112.152 179.689 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 2.4 p-10 -177.27 14.39 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.392 -0.817 . . . . 0.0 109.245 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -45.33 -81.62 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.361 -0.837 . . . . 0.0 109.696 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -155.07 -18.08 0.11 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.161 -0.962 . . . . 0.0 109.615 -179.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 1.15 HG22 ' H ' ' A' ' 118' ' ' THR . 19.0 m -74.2 -164.37 0.24 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.124 -0.985 . . . . 0.0 109.629 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 1.15 ' H ' HG22 ' A' ' 117' ' ' THR . 0.2 OUTLIER -166.25 -79.18 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.319 -0.863 . . . . 0.0 109.602 -179.36 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ASP . . . . . 0.516 ' H ' HG23 ' A' ' 118' ' ' THR . 1.0 OUTLIER -60.38 145.47 47.8 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.331 -0.856 . . . . 0.0 109.744 -179.823 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.789 HD11 ' HE2' ' A' ' 109' ' ' LYS . 7.1 mt -62.57 -40.17 96.01 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.333 -0.854 . . . . 0.0 109.434 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.425 ' C ' ' O ' ' A' ' 120' ' ' LEU . 21.0 mt-10 -44.5 -59.38 2.47 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.221 -0.925 . . . . 0.0 109.36 -179.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -50.49 -58.16 6.4 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.224 -0.923 . . . . 0.0 109.339 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.592 ' CB ' ' SD ' ' A' ' 112' ' ' MET . . . -63.78 -56.59 14.35 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.299 -0.875 . . . . 0.0 109.197 179.726 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.714 ' HB1' ' CH2' ' A' ' 101' ' ' TRP . . . -44.47 -58.87 2.72 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.305 -0.872 . . . . 0.0 109.238 179.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . 0.474 ' O ' ' N ' ' A' ' 129' ' ' GLY . 8.4 ttt180 -49.59 -52.76 28.09 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.416 -0.803 . . . . 0.0 108.995 179.695 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.501 ' O ' ' OG ' ' A' ' 130' ' ' SER . 18.7 ttm -50.28 -36.98 33.79 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.219 -0.926 . . . . 0.0 108.845 179.462 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' ILE . . . . . 0.816 HG13 ' HB2' ' A' ' 108' ' ' ALA . 15.6 mm -76.25 -77.19 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.355 -0.841 . . . . 0.0 109.275 179.677 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.437 ' C ' ' O ' ' A' ' 127' ' ' ILE . . . -44.94 -32.66 1.7 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.247 -0.908 . . . . 0.0 108.628 179.638 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . 0.474 ' N ' ' O ' ' A' ' 125' ' ' ARG . . . -65.31 -61.07 6.02 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.013 -1.635 . . . . 0.0 109.013 179.564 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . 0.501 ' OG ' ' O ' ' A' ' 126' ' ' MET . 4.8 m -45.03 -44.68 10.27 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.204 -1.174 . . . . 0.0 108.474 179.377 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -60.5 -46.79 88.82 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 179.221 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 2.4 tmt_? -49.78 -48.77 50.26 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.31 -0.869 . . . . 0.0 108.703 179.382 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.568 ' C ' ' H ' ' A' ' 135' ' ' GLY . 5.5 t -62.72 -35.81 80.94 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.337 -0.852 . . . . 0.0 108.714 179.349 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' MET . . . . . 0.621 ' HG2' HG23 ' A' ' 136' ' ' VAL . 8.3 ttp -68.78 23.2 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.436 -0.79 . . . . 0.0 109.284 179.641 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.568 ' H ' ' C ' ' A' ' 133' ' ' SER . . . 66.85 -11.74 0.6 Allowed Glycine 0 N--CA 1.489 2.21 0 N-CA-C 108.525 -1.83 . . . . 0.0 108.525 -179.173 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.621 HG23 ' HG2' ' A' ' 134' ' ' MET . 24.7 t -69.88 156.95 6.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.53 -0.982 . . . . 0.0 109.56 179.763 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.409 ' N ' ' CG1' ' A' ' 136' ' ' VAL . 3.3 tt0 -127.92 145.48 50.94 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.25 -0.906 . . . . 0.0 109.577 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . . 1.9 t -77.67 99.5 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.254 -0.904 . . . . 0.0 109.328 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.685 ' CG1' HG22 ' A' ' 100' ' ' THR . 1.3 p -52.86 -39.95 33.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.278 -0.889 . . . . 0.0 109.579 -179.699 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' GLY . . . . . 0.578 ' O ' ' HB3' ' A' ' 141' ' ' ALA . . . -102.9 -146.66 17.7 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.968 -1.253 . . . . 0.0 109.968 -179.599 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.578 ' HB3' ' O ' ' A' ' 140' ' ' GLY . . . 69.1 63.06 0.58 Allowed Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.367 -1.078 . . . . 0.0 109.329 -179.63 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' PRO . . . . . 0.482 ' HD3' ' N ' ' A' ' 141' ' ' ALA . 1.3 Cg_endo -65.56 128.4 20.07 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 C-N-CA 121.738 1.626 . . . . 0.0 112.608 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -76.42 67.78 2.67 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.228 -0.92 . . . . 0.0 109.316 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.437 ' H ' HG22 ' A' ' 144' ' ' VAL . 3.1 m -79.41 94.38 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.274 -0.891 . . . . 0.0 109.569 -179.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 14.9 mttt -113.13 44.26 1.56 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.264 -0.898 . . . . 0.0 109.432 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . 0.515 ' OD1' ' N ' ' A' ' 147' ' ' ALA . 1.4 p30 -171.19 -37.72 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.212 -0.93 . . . . 0.0 109.588 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.515 ' N ' ' OD1' ' A' ' 146' ' ' ASP . . . . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 118.013 -0.994 . . . . 0.0 109.368 -179.809 . . . . . . . . 1 1 . 1 stop_ save_